Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models

No abstract is available for this paper.

• Publication year

  2013

• Venue

  British Journal of Pharmacology

• Publication date

  2013-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bph.12255PMID 23713413PMCID PMC3834749
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PI3K/Akt signalling is required for the attachment and spreading, and growth in vivo of metastatic scirrhous gastric carcinoma

  2012cited by this paper
• Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells

  2012cited by this paper
• Downregulation of Akt and FAK phosphorylation reduces invasion of glioblastoma cells by impairment of MT1-MMP shuttling to lamellipodia and downregulates MMPs expression.

  2011cited by this paper
• Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.

  2010cited by this paper
• Guidelines for reporting experiments involving animals: the ARRIVE guidelines

  2010cited by this paper
• B7h Triggering Inhibits Umbilical Vascular Endothelial Cell Adhesiveness to Tumor Cell Lines and Polymorphonuclear Cells

  2010cited by this paper
• Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway.

  2010cited by this paper
• Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines

  2010cited by this paper
• Identification of CKD-516: a potent tubulin polymerization inhibitor with marked antitumor activity against murine and human solid tumors.

  2010influential reference
• Preclinical and clinical studies of anticancer agent‐incorporating polymer micelles

  2009cited by this paper
• Nanoparticle-based targeted drug delivery.

  2009cited by this paper
• Current and potential inflammation targeted therapies in head and neck cancer.

  2009cited by this paper
• Reconstitution of immunodeficient SCID/beige mice with human cells: applications in preclinical studies.

  2008cited by this paper
• Nanoparticle therapeutics: an emerging treatment modality for cancer

  2008influential reference
• Cholesterylbutyrate Solid Lipid Nanoparticles as a Butyric Acid Prodrug

  2008cited by this paper
• Activation of PI3K‐Akt signaling pathway promotes prostate cancer cell invasion

  2007cited by this paper
• PI3 kinase-AKT-mTOR pathway is essential for neuroendocrine differentiation of prostate cancer

  2007cited by this paper
• Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.

  2007influential reference
• Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells

  2006cited by this paper
• Conditional Akt activation promotes androgen-independent progression of prostate cancer.

  2006cited by this paper
• Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo.

  2006cited by this paper
• Phosphatidylinositol 3-Kinase-AKT-Mammalian Target of Rapamycin Pathway Is Essential for Neuroendocrine Differentiation of Prostate Cancer*

  2006cited by this paper
• Characterization of the activities of actin-affecting drugs on tumor cell migration.

  2006cited by this paper
• Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

  2006influential reference
• The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells

  2005cited by this paper
• The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells

  2004cited by this paper
• Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells

  2004cited by this paper
• In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: Evaluation of antiproliferative activity and apoptosis induction

  2004cited by this paper
• Sodium Butyrate Inhibits Cell Growth and Stimulates p21WAF1/CIP1 Protein in Human Colonic Adenocarcinoma Cells Independently of p53 Status

  2003cited by this paper
• Involvement of the PI 3-kinase signaling pathway in progression of colon adenocarcinoma.

  2003cited by this paper
• Prebiotics: actual and potential effects in inflammatory and malignant colonic diseases

  2003cited by this paper
• Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma

  2002cited by this paper
• AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis.

  2002cited by this paper
• Protective role of probiotics and prebiotics in colon cancer.

  2001cited by this paper
• Cholesteryl butyrate in solid lipid nanospheres as an alternative approach for butyric acid delivery.

  1999cited by this paper
• Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.

  1996cited by this paper
• Homozygous scid/scid;beige/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation

  1993cited by this paper
• Establishment of multidrug resistant human colorectal carcinoma HCT-15 cell lines and their properties.

  1991cited by this paper

• Inhibiting cancer metastasis with water-solubilized membrane receptor CXCR4QTY-Fc as a molecular trap.

  2025cites this paper
• Harnessing unique architecture and emerging strategies of solid lipid nanoparticles to combat colon cancer: A state-of-the-art review.

  2025cites this paper
• Enhancing cancer therapy: The role of drug delivery systems in STAT3 inhibitor efficacy and safety.

  2024cites this paper
• Butyrate Increases Heparin Synthesis and Storage in Human Mast Cells

  2024cites this paper
• Integrated analysis of transcriptomics and metabolomics in human hepatocellular carcinoma HepG2215 cells after YAP1 knockdown.

  2022cites this paper
• RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment

  2022cites this paper
• Mechanisms of solid lipid nanoparticles-triggered signaling pathways in eukaryotic cells.

  2022cites this paper
• In situ delivery of biobutyrate by probiotic Escherichia coli for cancer therapy

  2021cites this paper
• Effects of Intestinal Microbial–Elaborated Butyrate on Oncogenic Signaling Pathways

  2019cites this paper
• Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease

  2019cites this paper
• Polyethylene Glycol-Encapsulated Histone Deacetylase Inhibitor Drug-Composite Nanoparticles for Combination Therapy with Artesunate

  2018cites this paper
• Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model

  2017cites this paper
• Development of lipid nanoparticles for a histone deacetylases inhibitor as a promising anticancer therapeutic

  2016cites this paper
• Enhanced anti-cancer activity by co-delivery of docetaxel and perifosine with multifunctional nanoparticles via regulation of PI3K/Akt signalling pathway

  2015cites this paper
• Lipid prodrug nanocarriers in cancer therapy.

  2015influential citation
• Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models.

  2015cites this paper
• Physico-chemical characterisation, cytotoxic activity, and biocompatibility studies of tamoxifen-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification method

  2014cites this paper